These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 9632569)

  • 1. Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters.
    Roberts M; Li J; Bacon A; Chatfield S
    Infect Immun; 1998 Jul; 66(7):3080-7. PubMed ID: 9632569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prior immunity to homologous and heterologous Salmonella serotypes suppresses local and systemic anti-fragment C antibody responses and protection from tetanus toxin in mice immunized with Salmonella strains expressing fragment C.
    Roberts M; Bacon A; Li J; Chatfield S
    Infect Immun; 1999 Aug; 67(8):3810-5. PubMed ID: 10417142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the nirB promoter to direct the stable expression of heterologous antigens in Salmonella oral vaccine strains: development of a single-dose oral tetanus vaccine.
    Chatfield SN; Charles IG; Makoff AJ; Oxer MD; Dougan G; Pickard D; Slater D; Fairweather NF
    Biotechnology (N Y); 1992 Aug; 10(8):888-92. PubMed ID: 1368983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of abilities of Salmonella enterica serovar typhimurium aroA aroD and aroA htrA mutants to act as live vectors.
    Roberts M; Chatfield S; Pickard D; Li J; Bacon A
    Infect Immun; 2000 Oct; 68(10):6041-3. PubMed ID: 10992518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel use of anaerobically induced promoter, dmsA, for controlled expression of fragment C of tetanus toxin in live attenuated Salmonella enterica serovar Typhi strain CVD 908-htrA.
    Orr N; Galen JE; Levine MM
    Vaccine; 2001 Feb; 19(13-14):1694-700. PubMed ID: 11166893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Salmonella typhimurium htrA live vaccine expressing multiple copies of a peptide comprising amino acids 8-23 of herpes simplex virus glycoprotein D as a genetic fusion to tetanus toxin fragment C protects mice from herpes simplex virus infection.
    Chabalgoity JA; Khan CM; Nash AA; Hormaeche CE
    Mol Microbiol; 1996 Feb; 19(4):791-801. PubMed ID: 8820649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential induction of carrier antigen-specific immunity by Salmonella typhimurium live-vaccine strains after single mucosal or intravenous immunization of BALB/c mice.
    Karem KL; Chatfield S; Kuklin N; Rouse BT
    Infect Immun; 1995 Dec; 63(12):4557-63. PubMed ID: 7591105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal and systemic immune responses to chimeric fimbriae expressed by Salmonella enterica serovar typhimurium vaccine strains.
    Chen H; Schifferli DM
    Infect Immun; 2000 Jun; 68(6):3129-39. PubMed ID: 10816454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of protective immunity against Streptococcus mutans colonization after mucosal immunization with attenuated Salmonella enterica serovar typhimurium expressing an S. mutans adhesin under the control of in vivo-inducible nirB promoter.
    Huang Y; Hajishengallis G; Michalek SM
    Infect Immun; 2001 Apr; 69(4):2154-61. PubMed ID: 11254570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens.
    Galen JE; Gomez-Duarte OG; Losonsky GA; Halpern JL; Lauderbaugh CS; Kaintuck S; Reymann MK; Levine MM
    Vaccine; 1997; 15(6-7):700-8. PubMed ID: 9178472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of in vivo-regulated promoters to deliver antigens from attenuated Salmonella enterica var. Typhimurium.
    Dunstan SJ; Simmons CP; Strugnell RA
    Infect Immun; 1999 Oct; 67(10):5133-41. PubMed ID: 10496887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccination against type F botulinum toxin using attenuated Salmonella enterica var Typhimurium strains expressing the BoNT/F H(C) fragment.
    Foynes S; Holley JL; Garmory HS; Titball RW; Fairweather NF
    Vaccine; 2003 Mar; 21(11-12):1052-9. PubMed ID: 12559779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of LacZ from the htrA, nirB and groE promoters in a Salmonella vaccine strain: influence of growth in mammalian cells.
    Everest P; Frankel G; Li J; Lund P; Chatfield S; Dougan G
    FEMS Microbiol Lett; 1995 Feb; 126(1):97-101. PubMed ID: 7896085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and immunogenicity of pertussis toxin S1 subunit-tetanus toxin fragment C fusions in Salmonella typhi vaccine strain CVD 908.
    Barry EM; Gomez-Duarte O; Chatfield S; Rappuoli R; Pizza M; Losonsky G; Galen J; Levine MM
    Infect Immun; 1996 Oct; 64(10):4172-81. PubMed ID: 8926085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sublingually administered Bacillus subtilis cells expressing tetanus toxin C fragment induce protective systemic and mucosal antibodies against tetanus toxin in mice.
    Amuguni JH; Lee S; Kerstein KO; Brown DW; Belitsky BR; Herrmann JE; Keusch GT; Sonenshein AL; Tzipori S
    Vaccine; 2011 Jun; 29(29-30):4778-84. PubMed ID: 21565244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the abilities of different attenuated Salmonella typhimurium strains to elicit humoral immune responses against a heterologous antigen.
    Dunstan SJ; Simmons CP; Strugnell RA
    Infect Immun; 1998 Feb; 66(2):732-40. PubMed ID: 9453634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo stability of recombinant plasmids in a vaccine strain of Salmonella enterica var. Typhimurium.
    Dunstan SJ; Simmons CP; Strugnell RA
    FEMS Immunol Med Microbiol; 2003 Jul; 37(2-3):111-9. PubMed ID: 12832114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A.
    Ward SJ; Douce G; Figueiredo D; Dougan G; Wren BW
    Infect Immun; 1999 May; 67(5):2145-52. PubMed ID: 10225867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization with recombinant Streptococcus gordonii expressing tetanus toxin fragment C confers protection from lethal challenge in mice.
    Medaglini D; Ciabattini A; Spinosa MR; Maggi T; Marcotte H; Oggioni MR; Pozzi G
    Vaccine; 2001 Feb; 19(15-16):1931-9. PubMed ID: 11228363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivery of the Pertactin/P.69 polypeptide of Bordetella pertussis using an attenuated Salmonella typhimurium vaccine strain: expression levels and immune response.
    Anderson R; Dougan G; Roberts M
    Vaccine; 1996 Oct; 14(14):1384-90. PubMed ID: 9004450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.